Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 3052000
Name of medicinal product: RYEQO
Active substances:
Relugolix+Estradiol+Norethisterone
Estonian, English, Latin
ATC code: H01CC54
Dosage form: film-coated tablet
Route of administration: oral use
Strengh: 40mg+1mg+0,5mg
Amount in package: 84TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Ryeqo is indicated in adult women of reproductive age for: - treatment of moderate to severe symptoms of uterine fibroids, - symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis (see section 5.1).
Safety features: Yes
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Last imported to Estonia: Never imported to Estonia
: This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Patients and healthcare professionals are asked to report any suspected adverse reactions to State Agency of Medicines.State Agency of Medicines
Marketing authorization holder: Gedeon Richter Plc. 
Marketing authorization number: EU/1/21/1565 
Marketing authorization issued on: July 16, 2021 
Marketing authorization expires on: July 20, 2026 
Marketing authorization procedure type: Centralised 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: March 4, 2024
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere